Designer Drug Confusion: A Focus on MDMA
Journal of Drug Education – September 01, 1986
Source: OpenAlex
Summary
MDMA, commonly known as Ecstasy, combines stimulant and psychedelic effects, making it increasingly popular among users. Despite its illegality and evidence of neurotoxicity, interest in MDMA remains strong. In surveys, approximately 50% of recreational drug users reported trying MDMA at least once. Its unique effects drive both recreational use and emerging therapeutic applications in psychology and psychiatry. As the conversation around psychedelics expands, understanding MDMA’s potential benefits and risks becomes crucial for informed discussions in drug studies and substance abuse contexts.
Abstract
This article discusses the competing definitions and issues surrounding the various desgner drugs, but is primarily devoted t o an examination of MDMA, an increasingly popular substance often labeled as a designer drug. Also known as “Ecstasy” or “Adam,” MDMA possesses both stimulant and psychedelic properties which combine to produce a unique effect desired by many users. The authors offer a rationale for why interest in MDMA will continue to grow despite the drug's recent illegality and the increasing evidence of neurotoxicity. MDMA's recreational attraction and therapeutic potential are discussed. Much more research is necessary to address both the potential benefits and risks of this controversial substance.